PURR
Hyperliquid Strategies Inc.
$8.97
-1.10% 2026-10-19
Financial Services
PURRSPY
1W
-13.7%
1M
-36.3%
3M
+27.2%
6M
+45.4%
YTD
+152.0%
1Y
–
Grades vs sector
Momentumno data–
Momentum
no data
Percentile within its GICS sector across the S&P 1500.
Growthno data–
Growth
no data
Percentile within its GICS sector across the S&P 1500.
Valueno data–
Value
no data
Percentile within its GICS sector across the S&P 1500.
Profitabilityno data–
Profitability
no data
Percentile within its GICS sector across the S&P 1500.
Revisionsno data–
Revisions
no data
30-day change in analysts' current-year EPS estimate; graded across covered stocks.
Our models
Not held by any of our 3 live models right now.
Momentum Top 15
not ranked (outside this model's universe or screens)
Quality Growthnot ranked (outside this model's universe or screens)
Momentum Blendnot in the current book
Key stats
Market cap$2.5B
P/E (trailing)2.8
P/E (forward)24.2
52-week range3.01 – 14.76
Revenue growth (YoY, latest qtr)–
Dividend yield0.00%
Analyst consensusStrong Buy (4)
Mean price target$22.32 (+149%)
Valuation & fundamentals
Bottom line
No cash-flow valuation
Model read-out from the numbers below, not advice. Score +1 (DCF counts double).
▲Net debt / EBITDA-0.3x
▲Analyst target+149% (4 analysts)
Discounted cash flow
Trailing free cash flow is negative or missing, so a cash-flow DCF isn't meaningful by default. You can enter your own assumptions below.
Reverse DCFfor context, not a signal
A normal DCF guesses future cash flows and works out a price. A reverse DCF runs it backwards: it starts from today's price and asks how fast free cash flow would have to grow to justify it. It tells you what the market is assuming, not whether the stock is cheap or expensive, and it is not a buy or sell signal. Glossary
Trailing free cash flow is zero or negative, so there's no growth rate to solve for. The price is betting on a turnaround to positive cash flow.
Edit assumptions · recalculates instantly
Your value per share–
Free cash flow = operating cash flow − capital spending, trailing 12 months (FY to 2026-06-30). Growth default: average of 3-year revenue CAGR and latest revenue growth, capped at 30%. Years 6–10 fade linearly to terminal growth. Discount rate = 4.25% risk-free assumption + beta 1.00 (n/a) × 5% equity premium, kept within 7–13%. Bear: lower growth, +1 pt discount, 2% terminal. Bull: higher growth, −1 pt, 3%.
Multiples vs sector
Forward EPS $0.37 vs trailing $3.21 (-88% expected growth). Forward P/E uses analysts' next-12-month estimate.
Quality & financial health
Gross margin
–
Operating margin
5292.0%
FCF margin
-202.4%
Net margin
3229.8%
Return on equity
16.3%
Return on invested capital
18.8%
Net debt / EBITDA
-0.3×
Current ratio
41.6×
Interest cover
–
Cash conversion (OCF/NI)
-0.1×
Analysts
Mean target
$22
+149%
Analysts
4
Strong Buy
Range
$17–$34
low – high
● price · ◆ mean target
Annual history
| FY | Revenue | Net income | Free cash flow |
|---|---|---|---|
| 2026 | $9.5M | $305.5M | $-19.1M |
From the company's 10-K filings via SEC XBRL. 3-year revenue CAGR –.
Earnings
Next report: 2026-11-16 · before open · EPS est 0.21
EstimateActual (beat)Actual (miss)
| Report | EPS est | Actual | Surprise |
|---|---|---|---|
| 2026-08-27 | 0.78 | -0.86 | -210.3% |
| 2026-05-08 | 0.21 | 1.01 | +373.4% |
| 2026-02-11 | 0.55 | -6.56 | -1292.2% |
| 2026-02-11 | -4.12 | -6.56 | -59.2% |
Quarterly revenue
| Quarter | Revenue | YoY |
|---|---|---|
| 2026-06-30 | $6.3M | – |
| 2026-03-31 | $2.6M | – |
| 2025-12-31 | $500.0K | – |
| 2025-09-30 | $0 | – |
Analyst actions
Compass Point
PT $18
2026-09-15 · init
→ BuyPT $18
Cantor Fitzgerald
PT $34
2026-09-10 · main
Overweight → OverweightPT $34
Chardan Capital
PT $17
2026-08-28 · main
Buy → BuyPT $17
Chardan Capital
PT $10
2026-08-27 · main
Buy → BuyPT $10
Cantor Fitzgerald
PT $18
2026-07-01 · main
Overweight → OverweightPT $18
Chardan Capital
PT $10
2026-06-12 · main
Buy → BuyPT $10
Insider trades
None
–
None · None
SELL–
None
–
None · None
SELL–
None
–
None · None
SELL–
None
–
None · None
SELL–
None
–
None · None
SELL–
None
–
None · None
SELL–
None
–
None · None
SELL–
None
–
None · None
SELL–
None
–
None · None
SELL–
None
–
None · None
SELL–
None
–
None · None
SELL–
None
–
None · None
SELL–
News
Circle, Hyperliquid Buck The Trend as Most Crypto IPO Stocks Plunge
CryptoProwl · 16h ago
LEMME GOES BIG WITH BEST-SELLERS PURR AND SLEEP DEBUT AT SAM'S CLUB
PR Newswire · Oct 16
House Targets Hyperliquid in Insider Trading Probe, Cites $1.1B Crypto Short Before Trump Tariffs
Benzinga Prediction Markets · Sep 29
Binance’s High-Risk Seed Tag for Hyperliquid: What It Means for Investors
24/7 Wall St. · Sep 27
What Changed for Hyperliquid ETFs in September?
24/7 Wall St. · Sep 26
Top Premarket Gainers
MT Newswires · Sep 18
Wall Street Analysts See a 100.25% Upside in Hyperliquid Strategies Inc (PURR): Can the Stock Really Move This High?
Zacks · Sep 15
PURR Stock: Compass Point Calls For 63% Upside, HYPE Treasury Bet Nears $2.5B
Stocktwits · Sep 15
Stats refreshed 2026-10-19 19:02:34 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now
coteau
Coteau Systematic StrategiesSystematic equity research and model portfolios.Coteau Systematic Strategies publishes research, model portfolios and tools. It does not manage money or offer investment advice. Model results are hypothetical. Data: Yahoo Finance (delayed), SEC EDGAR.